THE relation of fever to juvenile rheumatoid arthritis appears to have been largely overlooked in the period of almost seventy years since Still 1 first called attention to certain distinctive ...

Researchers at National Jewish Health found that a subset of children suffering recurring fevers as a result of long COVID-19, benefited from a daily medication treatment commonly used for gout and ...

Aug. 1 -- FRIDAY, July 31 (HealthDay News) -- Colcrys has been approved by the U.S. Food and Drug Administration to treat acute gout and familial Mediterranean fever (FMF), two inflammatory disorders.

Please provide your email address to receive an email when new articles are posted on . Treatment with canakinumab resulted in rapid, sustained improvements in active systemic juvenile idiopathic ...

Colchicine is a generic prescription medication used to prevent gout flares and treat familial Mediterranean fever (FMF) in adults and certain children. Like most drugs, colchicine can cause side ...

Gout is the most common type of inflammatory arthritis in the world and is caused by the buildup of uric acid crystals in your joints. These crystals form when there’s too much uric acid in your blood ...

Biologics and Cancer Risk in RA: A Treatment Guide Dr. Jon Kay explores the relationship between anti-TNF therapy in patients with rheumatoid arthritis and the risk for malignancy. Medscape ...

Gout pain can get worse at night for a number of reasons, such as changes in your hormones, changes in your body position, and fewer distractions. Gout is a type of arthritis resulting from uric acid ...

Although rates vary widely between countries, the total number of young people with the condition is expected to continue rising through 2035.

The FDA has approved Colcrys (colchicine tablets, from AR Scientific), a single-ingredient oral colchicine product, for the treatment of familial Mediterranean fever (FMF) in patients ≥4 years of age ...